Found 52 results in Expert Content

Summary: Join this webinar to discover the current state of patient-focused dose design through clinical evidence, real-world case studies and patient preference-driven drug design solutions that can help develop better treatments and successful real-world outcomes.

Summary: Catalyst + Talent. Our name combines these ideas. From drug and biologic development to delivery technologies and supply solutions, we are the catalyst for your...

Summary: ​This Endpoints News webinar brings four experts who represent some of the key constituencies when developing a modern orphan program - from early research through approval.

Summary: ​Technology transfer and scale-up from a laboratory-scale to commercial-scale HME process require several in-depth empirical studies during product development. Without prior calculations and in-silico scale-up...

Summary: In this webinar, industry experts discuss the recent advances, challenges and considerations in pediatric drug development. Real-life examples presented by the experts...

Summary: ​Patient-focused drug design can be a key factor in real-world therapeutic outcomes and business success. But if successful treatments should be created with patients in mind...

Summary: Customers work with Catalent because they know that they can come to us and have their most difficult problems solved. They also come to us because there's no other company out there...

Summary: Determining a client’s primary goal is critical to guiding them through the development of their asset. Three experienced industry colleagues recently presented on the latest tips...

Summary: On July 31, 2014, Catalent officially listed on the NYSE. Take a look behind the scenes at the NYSE on listing and closing bell day.

Summary: With over 80 years serving the industry, Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products....